Today Opportunities Markets Hot News AI Chat

EN

Tickwind

Read every tick. See where the market's blowing.

Product

Markets
Theme Zones
All stocks
Compare
Hot stocks
Opportunities
News
Discussion
Watchlist
What's new

Account

Settings
Newsletter
Contact
Log in
Sign up

Markets Theme Zones All stocks Compare Hot stocks Opportunities News Discussion Watchlist What's new Settings Newsletter Contact Log in Sign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

4D Molecular Therapeutics, Inc. (FDMT) Gross margin — 10-Year History · Tickwind

Home/FDMT/Gross margin

4D Molecular Therapeutics, Inc. (FDMT) Gross margin

4D Molecular Therapeutics, Inc. (FDMT) gross margin by fiscal year — reported gross profit divided by reported revenue.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to FDMT

Source: SEC XBRL filings · For reference only · Not investment advice

More FDMT financial trends

FDMT Revenue FDMT Net income FDMT Net margin FDMT Gross profit FDMT Operating income FDMT Operating margin FDMT Operating cash flow FDMT Free cash flow FDMT Capital expenditures FDMT Return on equity

FDMT Stock buybacks

FDMT Dividends paid

FDMT Total assets

FDMT Total liabilities

FDMT Shareholders’ equity

FDMT overview →